This article is strictly informational. Possession, sale, or use of the substances discussed may be restricted under federal, state, or local law in your jurisdiction. Consult applicable regulations before any action.
Semaglutide dosage for alcohol craving reduction is not yet officially established in Canada, but early clinical data and patient reports suggest that the same weekly doses used for weight loss or diabetes, typically 0.25 mg to 2.4 mg, may also reduce the urge to drink. This article explains what is known about semaglutide for alcohol use disorder, how dosing works, and what Canadian patients should know before considering it off-label.
What the Research Says About Semaglutide and Alcohol Craving
Semaglutide is a GLP-1 receptor agonist originally approved for type 2 diabetes and later for weight management. It works by mimicking a gut hormone that regulates appetite, slows stomach emptying, and influences brain reward pathways. Researchers noticed that people taking semaglutide for weight loss often reported drinking less alcohol, sometimes without intending to cut back.
Animal studies provide strong evidence. In rodents and monkeys, semaglutide reduced alcohol intake and prevented relapse-like drinking. A 2023 study in JCI Insight found that semaglutide decreased alcohol drinking in rats by modulating the brain's reward system, specifically in areas linked to addiction. Human data is more limited but growing. A small 2024 clinical trial at the University of North Carolina found that low-dose semaglutide reduced heavy drinking days in people with alcohol use disorder. Participants receiving semaglutide drank less and had fewer cravings compared to placebo.
In Canada, no semaglutide product is approved for alcohol use disorder. However, off-label prescribing is legal when a physician judges it medically appropriate. Some Canadian addiction specialists are already using GLP-1 drugs like semaglutide as an adjunct for patients who struggle with both obesity and alcohol craving. For more on the Quebec perspective, see this discussion of a semaglutide alcohol study in Quebec.
How Semaglutide Dosing Works for Alcohol Craving
Because no dedicated alcohol craving dose exists, clinicians extrapolate from weight loss protocols. The standard titration schedule for semaglutide is:
- Weeks 1-4: 0.25 mg once weekly
- Weeks 5-8: 0.5 mg once weekly
- Weeks 9-12: 1.0 mg once weekly
- Weeks 13-16: 1.7 mg once weekly
- Week 17 onward: 2.4 mg once weekly (maintenance)
For alcohol craving, some doctors start at 0.25 mg and increase slowly to minimize nausea. The effective dose for reducing drinking may be lower than the full 2.4 mg. In the UNC trial, participants received 0.5 mg weekly for the first month, then 1.0 mg weekly. That modest dose still produced meaningful reductions in alcohol consumption.
Patients in Canada should not self-titrate. A physician familiar with GLP-1 drugs can adjust the dose based on side effects and response. If you are buying semaglutide from a research peptide supplier, you must reconstitute and dose it yourself, which carries additional risks. For guidance on purchasing semaglutide in Quebec, read this article on buying semaglutide 5mg online in Quebec.
Semaglutide vs. Other GLP-1 Drugs for Alcohol Craving
Semaglutide is not the only GLP-1 agonist being studied for alcohol use disorder. Tirzepatide, a dual GIP/GLP-1 agonist, and retatrutide, a triple agonist, may have even stronger effects on reward pathways. However, semaglutide has the most human data so far. A 2024 retrospective analysis of electronic health records found that people prescribed semaglutide or tirzepatide for diabetes or obesity had a 50% lower rate of alcohol use disorder diagnosis compared to those not on GLP-1 drugs.
For Canadian patients, semaglutide is widely available as Ozempic (for diabetes) and Wegovy (for weight loss). Both require a prescription. Some clinics offer compounded semaglutide, but Health Canada warns that compounded versions are not approved and may vary in quality. Research peptide suppliers sell semaglutide for laboratory use only, not for human consumption. If you are considering semaglutide for alcohol craving, talk to a doctor about the safest legal option.
What Dose of Semaglutide Reduces Alcohol Craving? Patient Reports
Patient anecdotes on forums like Reddit suggest that even the starting dose of 0.25 mg can blunt the desire to drink within the first week. Many report that alcohol simply becomes less appealing, and they stop thinking about it. Some say the effect plateaus until they reach 1.0 mg or higher. A common pattern is that semaglutide reduces the "reward" from alcohol, so drinking feels less satisfying.
One Canadian user described taking 0.5 mg weekly for weight loss and noticing that a glass of wine no longer gave the same buzz. Another said that after reaching 1.7 mg, they could not finish a single beer. These reports align with the mechanism: semaglutide dampens dopamine release in the nucleus accumbens, a brain region central to addiction. The effect is not a cure for alcoholism, but it can be a powerful tool when combined with counseling or support groups.
Semaglutide Alcohol Craving Dosage: Safety and Side Effects
The most common side effects of semaglutide are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These are dose-dependent and usually improve after a few weeks. Starting at 0.25 mg and increasing slowly reduces the risk. Other side effects include fatigue, headache, and dizziness. Rare but serious risks include pancreatitis, gallbladder disease, and thyroid C-cell tumors (seen in rodents, not confirmed in humans).
For people with alcohol use disorder, there are additional considerations. Heavy alcohol use can damage the liver and pancreas. Semaglutide may increase the risk of pancreatitis, especially in those with a history of the condition. Patients should have liver function tests before starting. Also, semaglutide can cause dehydration from vomiting or diarrhea, which is dangerous for someone who is also drinking heavily. Medical supervision is essential.
Health Canada has not approved semaglutide for alcohol craving. Any use for this purpose is off-label. That does not mean it is illegal, but it means the evidence is still emerging and the long-term effects in this population are unknown. For a broader look at how regulatory changes affect peptide research in Canada, see this analysis of the FDA panel's impact on BPC-157 research in Canada.
How to Get Semaglutide for Alcohol Craving in Canada
There are three main routes to obtain semaglutide in Canada:
- Prescription from a doctor: A physician can prescribe Ozempic or Wegovy off-label for alcohol craving. This is the safest option. The cost is often covered by private insurance if the patient has diabetes or obesity, but off-label use may not be covered.
- Compounding pharmacy: Some Canadian compounding pharmacies make semaglutide with a prescription. Health Canada does not regulate compounded drugs as strictly as approved products, so quality can vary.
- Research peptide suppliers: Online vendors sell semaglutide as a lyophilized powder for "research purposes only." This is not legal for human use in Canada, and the product is not tested for purity or sterility. Buying from these sources is risky.
If you choose to buy semaglutide from a research supplier, you will need to reconstitute the powder with bacteriostatic water and calculate your own dose. A 5 mg vial reconstituted with 2 mL of water gives a concentration of 2.5 mg/mL. To take 0.25 mg, you would draw 0.1 mL (10 units on an insulin syringe). This requires precise math and sterile technique. Mistakes can lead to overdose or infection. The safer path is to work with a Canadian doctor who can prescribe a regulated product.
Semaglutide Dosage for Alcohol Craving: What Canadian Doctors Say
Canadian addiction specialists are cautiously optimistic. Dr. Jordan Leith, an addiction psychiatrist in Toronto, says, "We are seeing patients who start semaglutide for weight loss and spontaneously report reduced alcohol intake. The effect is real, but we need larger trials before we can recommend it as a standard treatment." He notes that semaglutide is not a substitute for therapy or mutual help groups, but it can be a useful adjunct for patients who struggle with both obesity and alcohol use.
In Quebec, a 2024 pilot study at McGill University is testing semaglutide in people with alcohol use disorder and no diabetes. The trial uses a dose of 1.0 mg weekly after a four-week titration. Early results are promising, with participants reporting fewer cravings and less drinking. The study is expected to finish in 2026. For more on that research, see this summary of the Quebec semaglutide alcohol study.
Semaglutide vs. Naltrexone for Alcohol Craving
Naltrexone is an FDA-approved medication for alcohol use disorder. It works by blocking opioid receptors, which reduces the rewarding effects of alcohol. Semaglutide works through a different mechanism, affecting GLP-1 receptors and dopamine signaling. Some researchers believe the two drugs could be complementary. A 2025 animal study found that combining semaglutide with naltrexone produced a greater reduction in alcohol intake than either drug alone.
For Canadian patients, naltrexone is cheap and widely available. Semaglutide is more expensive and not approved for this use. However, semaglutide has the added benefit of weight loss, which many patients with alcohol use disorder also need. The choice depends on individual goals and medical history. A doctor can help weigh the options.
Practical Tips for Using Semaglutide to Reduce Alcohol Craving
If you and your doctor decide to try semaglutide for alcohol craving, follow these steps:
- Start low and go slow: Begin at 0.25 mg weekly for at least four weeks.
- Track your drinking: Keep a log of drinks per day and craving intensity.
- Stay hydrated: Semaglutide can cause dehydration, which worsens hangovers.
- Avoid heavy alcohol use: Drinking large amounts while on semaglutide can cause
This article is strictly informational. Possession, sale, or use of the substances discussed may be restricted under federal, state, or local law in your jurisdiction. Consult applicable regulations before any action.